$6.76 Billion is the total value of Redmile Group, LLC's 86 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 18.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $1,124,557,000 | +5.3% | 12,957,222 | 0.0% | 16.64% | +10.6% | |
| IGMS | IGM BIOSCIENCES INC | $284,998,000 | +8.5% | 3,425,455 | 0.0% | 4.22% | +14.0% | |
| BEAM | Sell | BEAM THERAPEUTICS INC | $264,178,000 | +30.3% | 2,052,506 | -19.0% | 3.91% | +36.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $237,930,000 | +1.7% | 790,282 | -7.0% | 3.52% | +6.8% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $200,505,000 | -3.9% | 20,799,303 | -1.5% | 2.97% | +1.0% |
| ALLK | Sell | ALLAKOS INC | $189,265,000 | -31.8% | 2,216,996 | -8.4% | 2.80% | -28.4% |
| ADCT | Buy | ADC THERAPEUTICS SA | $183,161,000 | +2.7% | 7,522,029 | +2.9% | 2.71% | +7.8% |
| STTK | SHATTUCK LABS INC | $162,921,000 | -0.9% | 5,619,914 | 0.0% | 2.41% | +4.1% | |
| REPL | Buy | REPLIMUNE GROUP INC | $161,038,000 | +28.2% | 4,191,512 | +1.8% | 2.38% | +34.6% |
| NVTA | Sell | INVITAE CORP | $156,757,000 | -15.4% | 4,647,393 | -4.2% | 2.32% | -11.1% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $155,399,000 | -20.4% | 4,244,721 | -2.5% | 2.30% | -16.3% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $152,788,000 | +12.1% | 860,101 | +3.7% | 2.26% | +17.8% |
| MDVL | MEDAVAIL HOLDINGS INC | $143,628,000 | -12.5% | 11,724,726 | 0.0% | 2.12% | -8.1% | |
| KRYS | Buy | KRYSTAL BIOTECH INC | $140,905,000 | -11.2% | 2,072,132 | +0.6% | 2.08% | -6.7% |
| OSH | Sell | OAK STR HEALTH INC | $134,866,000 | -15.2% | 2,302,653 | -21.4% | 2.00% | -10.9% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $122,778,000 | +21.4% | 2,531,508 | -2.8% | 1.82% | +27.5% |
| SGEN | Sell | SEAGEN INC | $121,786,000 | -6.4% | 771,385 | -17.7% | 1.80% | -1.7% |
| VERV | New | VERVE THERAPEUTICS INC | $116,676,000 | – | 1,936,530 | +100.0% | 1.73% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $106,735,000 | – | 6,353,246 | +100.0% | 1.58% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $100,724,000 | +44.3% | 3,012,081 | -11.1% | 1.49% | +51.6% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $100,291,000 | +1.4% | 6,449,577 | -6.3% | 1.48% | +6.5% |
| NVRO | Buy | NEVRO CORP | $98,601,000 | +36.8% | 594,732 | +15.1% | 1.46% | +43.7% |
| DXCM | Buy | DEXCOM INC | $98,448,000 | +23.1% | 230,558 | +3.6% | 1.46% | +29.4% |
| LIVN | Sell | LIVANOVA PLC | $93,504,000 | +13.2% | 1,111,684 | -0.7% | 1.38% | +19.0% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $91,914,000 | -27.1% | 3,156,401 | -1.6% | 1.36% | -23.5% |
| NRIX | Sell | NURIX THERAPEUTICS INC | $84,633,000 | -17.9% | 3,190,077 | -3.7% | 1.25% | -13.7% |
| RGNX | Sell | REGENXBIO INC | $83,069,000 | +4.1% | 2,138,201 | -8.6% | 1.23% | +9.3% |
| STOK | Sell | STOKE THERAPEUTICS INC | $82,755,000 | -16.2% | 2,458,558 | -3.4% | 1.22% | -12.0% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $81,829,000 | +0.0% | 2,624,396 | -1.5% | 1.21% | +5.1% |
| ANNX | Sell | ANNEXON INC | $77,098,000 | -19.9% | 3,425,038 | -1.0% | 1.14% | -15.9% |
| EPZM | Sell | EPIZYME INC | $70,760,000 | -7.9% | 8,515,060 | -3.5% | 1.05% | -3.3% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $69,591,000 | -4.6% | 2,804,944 | +11.6% | 1.03% | +0.3% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $66,673,000 | -39.5% | 2,307,028 | +6.0% | 0.99% | -36.4% |
| PRTA | Sell | PROTHENA CORP PLC | $62,497,000 | +34.0% | 1,215,657 | -34.5% | 0.92% | +40.8% |
| ZY | New | ZYMERGEN INC | $60,931,000 | – | 1,522,900 | +100.0% | 0.90% | – |
| IMGN | Sell | IMMUNOGEN INC | $58,525,000 | -25.4% | 8,880,945 | -8.3% | 0.87% | -21.6% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $55,110,000 | +150.8% | 1,666,963 | +196.4% | 0.82% | +162.9% |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $55,067,000 | -31.2% | 2,792,448 | +1.5% | 0.82% | -27.7% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $53,100,000 | -33.4% | 3,235,809 | -10.4% | 0.79% | -30.0% |
| GMAB | Sell | GENMAB A/Ssponsored ads | $50,122,000 | +14.6% | 1,227,588 | -7.9% | 0.74% | +20.5% |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $49,979,000 | -30.7% | 914,035 | -6.6% | 0.74% | -27.2% |
| SLQT | Buy | SELECTQUOTE INC | $46,454,000 | -21.5% | 2,411,957 | +20.3% | 0.69% | -17.5% |
| ICUI | Sell | ICU MED INC | $45,879,000 | -0.4% | 222,929 | -0.5% | 0.68% | +4.6% |
| NUVB | NUVATION BIO INC | $42,277,000 | -10.9% | 4,541,009 | 0.0% | 0.63% | -6.3% | |
| ANTM | Sell | ANTHEM INC | $41,540,000 | -11.3% | 108,801 | -16.6% | 0.62% | -6.7% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $40,090,000 | -17.0% | 108,374 | -35.0% | 0.59% | -12.8% |
| CI | Sell | CIGNA CORP NEW | $37,866,000 | -44.1% | 159,727 | -43.0% | 0.56% | -41.3% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $37,828,000 | -11.1% | 94,465 | -17.4% | 0.56% | -6.5% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $36,175,000 | -28.6% | 3,919,235 | -4.8% | 0.54% | -25.1% |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $35,022,000 | – | 1,257,067 | +100.0% | 0.52% | – |
| CTLT | Sell | CATALENT INC | $33,529,000 | +2.2% | 310,111 | -0.5% | 0.50% | +7.4% |
| ZYME | Sell | ZYMEWORKS INC | $32,598,000 | +4.7% | 939,697 | -4.7% | 0.48% | +10.0% |
| AMED | Sell | AMEDISYS INC | $32,443,000 | -7.9% | 132,458 | -0.4% | 0.48% | -3.2% |
| ALVR | Sell | ALLOVIR INC | $31,270,000 | -31.2% | 1,584,093 | -18.5% | 0.46% | -27.8% |
| LVTX | Sell | LAVA THERAPEUTICS NV | $30,640,000 | -28.6% | 2,816,196 | -0.3% | 0.45% | -25.0% |
| RCEL | Sell | AVITA MEDICAL INC | $28,956,000 | -12.4% | 1,411,117 | -15.4% | 0.43% | -8.2% |
| ARDX | Buy | ARDELYX INC | $28,153,000 | +21.0% | 3,714,100 | +5.7% | 0.42% | +27.1% |
| BVS | Sell | BIOVENTUS INC | $26,170,000 | +14.2% | 1,486,956 | -0.9% | 0.39% | +19.8% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $22,636,000 | -76.5% | 425,480 | -80.8% | 0.34% | -75.3% |
| IMTX | Sell | IMMATICS N.V | $22,545,000 | -3.4% | 1,941,892 | -6.8% | 0.33% | +1.5% |
| PPD | Sell | PPD INC | $21,500,000 | -30.8% | 466,471 | -43.2% | 0.32% | -27.4% |
| BCEL | Sell | ATRECA INC | $20,961,000 | -45.1% | 2,460,268 | -1.2% | 0.31% | -42.4% |
| QSI | New | QUANTUM SI INC | $20,842,000 | – | 1,700,000 | +100.0% | 0.31% | – |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $20,442,000 | -40.8% | 2,088,089 | 0.0% | 0.30% | -38.0% | |
| GRTS | Sell | GRITSTONE BIO INC | $20,325,000 | -12.0% | 2,226,206 | -9.1% | 0.30% | -7.4% |
| ITMR | Sell | ITAMAR MED LTDsponsored ads | $20,133,000 | -8.5% | 854,900 | -7.0% | 0.30% | -3.9% |
| DYNS | New | DYNAMICS SPECIAL PURPOSE COR | $20,008,000 | – | 2,012,900 | +100.0% | 0.30% | – |
| INNV | Sell | INNOVAGE HLDG CORP | $17,977,000 | -18.0% | 843,578 | -0.8% | 0.27% | -13.9% |
| STXS | Sell | STEREOTAXIS INC | $17,887,000 | -17.9% | 1,855,504 | -42.8% | 0.26% | -13.7% |
| TKNO | New | ALPHA TEKNOVA INC | $17,204,000 | – | 725,000 | +100.0% | 0.26% | – |
| HOOK | Buy | HOOKIPA PHARMA INC | $17,003,000 | -31.4% | 1,856,205 | +0.7% | 0.25% | -27.8% |
| QTRX | Sell | QUANTERIX CORP | $14,133,000 | -19.4% | 240,933 | -19.7% | 0.21% | -15.4% |
| PROF | Sell | PROFOUND MED CORP | $12,881,000 | -24.4% | 787,346 | -6.9% | 0.19% | -20.4% |
| TMCI | New | TREACE MED CONCEPTS INC | $10,121,000 | – | 323,765 | +100.0% | 0.15% | – |
| CTSO | Sell | CYTOSORBENTS CORP | $9,848,000 | -46.7% | 1,304,369 | -38.7% | 0.15% | -43.8% |
| AYLA | AYALA PHARMACEUTICALS INC | $6,805,000 | -6.6% | 667,816 | 0.0% | 0.10% | -1.9% | |
| STIM | Sell | NEURONETICS INC | $6,318,000 | +2.2% | 394,355 | -21.1% | 0.09% | +6.9% |
| CABA | CABALETTA BIO INC | $5,989,000 | -22.5% | 696,378 | 0.0% | 0.09% | -18.3% | |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $5,530,000 | -28.4% | 1,358,825 | -20.6% | 0.08% | -24.8% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $5,098,000 | -92.9% | 237,360 | -79.5% | 0.08% | -92.6% |
| TLIS | Sell | TALIS BIOMEDICAL CORP | $4,013,000 | -21.9% | 363,849 | -9.0% | 0.06% | -18.1% |
| APRE | APREA THERAPEUTICS INC | $3,391,000 | -4.3% | 694,918 | 0.0% | 0.05% | 0.0% | |
| YMTX | Sell | YUMANITY THERAPEUTICS INC | $693,000 | -93.7% | 59,487 | -90.3% | 0.01% | -93.6% |
| TCDA | TRICIDA INC | $237,000 | -18.3% | 54,758 | 0.0% | 0.00% | 0.0% | |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $212,000 | -86.6% | 38,912 | -81.7% | 0.00% | -86.4% |
| OVID | Sell | OVID THERAPEUTICS INC | $159,000 | -67.6% | 40,674 | -66.6% | 0.00% | -71.4% |
| CSLT | Exit | CASTLIGHT HEALTH INCcl b | $0 | – | -10,229 | -100.0% | 0.00% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -79,018 | -100.0% | -0.01% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -882,814 | -100.0% | -0.12% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -284,160 | -100.0% | -0.14% | – |
| VSPR | Exit | VESPER HEALTHCARE ACQSTN COR | $0 | – | -1,982,749 | -100.0% | -0.30% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -162,847 | -100.0% | -0.64% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -3,589,342 | -100.0% | -1.21% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -979,108 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.